R22C (p.Arg22Cys) variant of REL (Proto-oncogene c-Rel)

R22C (p.Arg22Cys) in REL (Proto-oncogene c-Rel) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.69 / 1. The record also includes structural context.

R22C (p.Arg22Cys) variant details